铂类药物在头颈部鳞癌治疗中的选择与应用

李文成; 王孝深

doi:10.19401/j.cnki.1007-3639.2019.04.010

您当前的位置：

首页 >

文章列表页 >

铂类药物在头颈部鳞癌治疗中的选择与应用

综述 | 更新时间：2026-01-27

- 铂类药物在头颈部鳞癌治疗中的选择与应用
- The selection and application of platinum drugs in the treatment of head and neck squamous cell carcinomas
- 中国癌症杂志 2019年29卷第4期页码：300-306
- 作者机构：
  
  1. 安徽医科大学第一附属医院放疗科,安徽,合肥,230022
  2. 复旦大学附属肿瘤医院放疗科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2019.04.010
  中图分类号： R739.91
- 网络出版：2019-05-17，
  
  纸质出版：2019-05-17
- 稿件说明：
移动端阅览
李文成，王孝深. 铂类药物在头颈部鳞癌治疗中的选择与应用[J]. 中国癌症杂志, 2019, 29(4): 300-306.

李文成, 王孝深. The selection and application of platinum drugs in the treatment of head and neck squamous cell carcinomas[J]. China Oncology, 2019, 29(4): 300-306.
李文成，王孝深. 铂类药物在头颈部鳞癌治疗中的选择与应用[J]. 中国癌症杂志, 2019, 29(4): 300-306. DOI： 10.19401/j.cnki.1007-3639.2019.04.010.

李文成, 王孝深. The selection and application of platinum drugs in the treatment of head and neck squamous cell carcinomas[J]. China Oncology, 2019, 29(4): 300-306. DOI： 10.19401/j.cnki.1007-3639.2019.04.010.

摘要

以铂类药物为基础的化疗成为晚期头颈部鳞癌（head and neck squamous cell carcinoma，HNSCC）综合治疗中不可缺少的部分。化疗可与放疗同步用于局部晚期HNSCC的根治性治疗，或用于具有高危因素的HNSCC术后辅助治疗，也可用于诱导化疗（新辅助化疗）或者放疗后的辅助化疗。同期放化疗在局部晚期HNSCC的治疗中尤其重要。几种常用的铂类药物在HNSCC的治疗中各有优势。本文简述铂类药物的药理作用及机制，比较铂类药物在HNSCC的疗效与毒性，并分析不同给药方式（单药或多药联合，每周或每3周）与给药剂量所带来的疗效与毒性差异，希望能对医师合理使用铂类药物治疗HNSCC有所裨益。

Abstract

Platinum-based chemotherapy has become an indispensable part in the comprehensive treatment of locally advanced head and neck squamous cell carcinomas (HNSCC). Chemotherapy can be used concurrently with radiotherapy (CCRT) for curative treatment of locally advanced HNSCC. CCRT is also widely applied after surgery for patients with high risk factors. In addition

chemotherapy is used before surgery or radiation (also known as neoadjuvant chemotherapy)

or after radiotherapy (adjuvant chemotherapy). CCRT is particularly important for locally advanced HNSCC. Several commonly used platinum drugs all have their own advantages and disadvantages in the treatment of HNSCC. This review includes the anticancer mechanisms and the efficacy and toxicities of the platinum drugs. In addition

several different dosing schedules are listed (high doses given every 3 weeks

moderate doses given weekly

single-agent platinum versus multi-agent platinum-containing regimens)

the short and long term survival data and toxicities are also provided

with the hope to give useful information for clinicians.

关键词

Keywords

references

浏览量

2999

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

周剂量多西他赛联合顺铂与周剂量多西他赛联合奥沙利铂治疗晚期胃癌的临床研究

培美曲塞联合铂类一线治疗晚期非鳞非小细胞肺癌的临床观察

鼻咽癌颅底骨侵犯的零回波时间磁共振成像诊断价值

鼻咽癌肝转移患者肝部分切除术与经导管动脉化疗栓塞术的远期疗效比较分析

奥沙利铂超敏反应全程管理中国专家共识（2024年版）